Psychedelics: A Complex and Changing Regulatory Landscape Focused on Scientific Research and IP Protection
CPD for Lawyers: 1 Substantive Hour
ACCESS ARCHIVE
The psychedelics industry has witnessed an explosion of new companies and new ideas over the past few years. In addition to the increased number of section 56 exemptions that have been granted, Health Canada’s highly anticipated amendments to the Special Access Program (“SAP”) now permit physicians to request access to psychedelics for eligible patients in limited circumstances. With a growing body of research, incremental liberalization of regulatory policies and governmental actions, and a grassroots change to the legal status of these substances, public opinion appears to be shifting in favour of access to psychedelics for medical purposes.Join our panel of industry experts for a complimentary webinar to learn about recent scientific research on psychedelic medicine, updates to the shifting regulatory landscape, and how to navigate the complex world of psychedelics regulation and patent protection today and in the future.
Topics include:
- Updates to the evolving regulatory landscape
- Cutting-edge areas of scientific research
- Requirements for obtaining patent protection and some jurisdictional differences
- Patent infringement and avoidance
For information regarding our webinars and communications, please contact:
Adrian Babrikels-Munoz | rsvp@airdberlis.com | 416.863.1500 x2541